Accounting Manager at Abata Therapeutics

South San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

7+ years of progressive accounting/finance experience, ideally a public accounting and private industry mix
CPA desired
Strong project management skills with the ability to manage competing priorities and meet tight deadlines
Demonstrated ability to manage external service providers and cross functional relationships
Self-starter with a collaborative mindset and a passion for working in a mission-driven organization
Biotech/pharmaceutical industry experience preferred
Proficiency in NetSuite and advanced Excel and Google Suite of products (Sheets, Docs) is a plus
Ability to prioritize assignments, deal with interruptions, and meet deadlines in a fast paced and growth oriented environment

Responsibilities

Participate in the month-end, quarter-end and year-end financial close process, preparing journal entries, balance sheet and income statement account reconciliations
Work on prepaid expenses, fixed assets, accrual liabilities, and flux analysis
Ensure all financial data is in compliance with the U.S. Generally Accepted Accounting Principles (GAAP)
Plan and design business processes and objectives and make recommendations and changes in order to improve and support scalability in the team organization, business systems and activities
Collaborate and coordinate with various business partners to obtain required financial reporting information and develop improvements to the financial reporting process
Ensure compliance with regulatory requirements, including tax filings, audit readiness, and financial reporting standards
Manage a third party accounting firm supporting day to day accounting operations including reviewing and approving invoices entered by AP contractor and correct GL/Dept/Class coding as appropriate
Able to deliver results in a fast-paced work environment

Skills

GAAP

Journal Entries

Account Reconciliations

Fixed Assets

Prepaid Expenses

Accruals

Flux Analysis

Month-End Close

Financial Reporting

Business Process Design

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free